DT-168

N/A

Report date: 2025/06/19 20:00:08
NME

Base Information

Drug NameDT-168
Drug Alias NameDT-168
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscription factor 4 inhibitors
TargetsTranscription factor 4
Therapy Area/IndicationsFuchs' Endothelial Dystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDesign Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDesign Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsFuchs' Endothelial Dystrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A